158P Triple blockade of the DNAM-axis with COM701 + BMS-986207 + nivolumab demonstrates preliminary antitumor activity in patients with platinum-resistant OVCA

Saved in:
Bibliographic Details
Published inImmuno-oncology technology Vol. 16; p. 100270
Main Authors Moroney, J., Yeku, O., Fleming, G., Emens, L.A., Vaena, D., Dumbrava, E.E., Rasco, D., Sharma, M.R., Papadopoulos, K., Patnaik, A., Sullivan, R.J., Adewoye, H.H., Ophir, E., Cojocaru, G., Ferre, P.J., Izar, B., Gaillard, S.
Format Journal Article
LanguageEnglish
Published 01.12.2022
Online AccessGet full text

Cover

More Information
ISSN:2590-0188
2590-0188
DOI:10.1016/j.iotech.2022.100270